Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)

China · Delayed Price · Currency is CNY

30.55

-1.70 (-5.27%)

May 21, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals		255.25M	225.14M	255.40M	285.14M	284.79M
Pharmaceuticals Growth		13.37%	-11.85%	-10.43%	0.12%	-12.35%
Unallocated Other Business		1.16M	350.04K	70.32K	514.50K	1.53M
Unallocated Other Business Growth		230.89%	397.79%	-86.33%	-66.37%	-
Total		256.41M	225.49M	255.47M	285.66M	286.32M
Total Growth		13.71%	-11.73%	-10.57%	-0.23%	-11.88%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China		256.41M	225.49M	255.47M	285.66M	286.32M
China Growth		13.71%	-11.73%	-10.57%	-0.23%	-11.88%
Total		256.41M	225.49M	255.47M	285.66M	286.32M
Total Growth		13.71%	-11.73%	-10.57%	-0.23%	-11.88%

Source: S&P Global Market Intelligence.